A new method to repair damaged cartilage in joints
A Novel Glycosaminoglycan Mimetic Scaffold for Cartilage Repair
['FUNDING_R01'] · COLUMBIA UNIV NEW YORK MORNINGSIDE · NIH-10918038
This study is looking at a new way to help people with cartilage injuries heal better by using a special technique and a supportive material that encourages the growth of healthy cartilage.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLUMBIA UNIV NEW YORK MORNINGSIDE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10918038 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the healing of articular cartilage, which has a limited ability to repair itself. It combines a surgical technique called microfracturing, which allows stem cells to migrate to the damaged area, with a novel scaffold that mimics the natural cartilage environment. This scaffold is designed to enhance the growth and formation of healthy cartilage tissue, potentially leading to better long-term outcomes for patients with cartilage injuries. The goal is to create a more effective treatment that results in the regeneration of normal cartilage rather than fibrocartilage.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cartilage injuries, particularly those who are experiencing symptoms and are under 21 years old.
Not a fit: Patients with advanced osteoarthritis or those who do not have cartilage injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for cartilage injuries, reducing the risk of developing osteoarthritis and enhancing joint function.
How similar studies have performed: Other research has shown promise in using biomimetic scaffolds for cartilage repair, indicating that this approach has potential based on previous successes.
Where this research is happening
NEW YORK, UNITED STATES
- COLUMBIA UNIV NEW YORK MORNINGSIDE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ARINZEH, TREENA LYNNE — COLUMBIA UNIV NEW YORK MORNINGSIDE
- Study coordinator: ARINZEH, TREENA LYNNE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.